Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Talis Biomedical Corp (NQ: TLIS )

4.380 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 4.380
Bid (Size) 4.050 (1)
Ask (Size) 4.380 (1)
Prev. Close 4.380
Today's Range 4.380 - 4.380
52wk Range 3.420 - 9.600
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Via Benzinga
TLIS Stock Earnings: Talis Biomedical Reported Results for Q2 2024
Talis Biomedical just reported results for the second quarter of 2024. 
Via InvestorPlace

Performance

YTD
-45.52%
-45.52%
1 Month
N/A
N/A
3 Month
+2.22%
+2.22%
6 Month
-52.08%
-52.08%
1 Year
-37.25%
-37.25%

More News

Read More
Dow Tumbles Over 200 Points; CVS Health Cuts Profit Forecast
Via Benzinga
Topics Stocks
Exposures US Equities
Crude Oil Jumps Over 3%; Upstart Shares Spike Higher
Via Benzinga
Exposures Fossil Fuels
Nasdaq Jumps 250 Points; Disney Earnings Beat Estimates
Via Benzinga
Topics Earnings
Exposures Financial
TLIS Stock Earnings: Talis Biomedical Reported Results for Q1 2024
Via InvestorPlace
TLIS Stock Earnings: Talis Biomedical Reported Results for Q4 2023
Via InvestorPlace
Why Talis Biomedical (TLIS) Stock Is Getting Obliterated Today
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Why Is Talis Biomedical (TLIS) Stock Down 52% Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
BTIG Maintains Sell Rating for Talis Biomedical: Here's What You Need To Know
Via Benzinga
A Preview Of Talis Biomedical's Earnings
Via Benzinga
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Talis, TaskUs, and RTR on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Talis Biomedical (TLIS) Stock Is Exploding Higher
Via Benzinga
Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
From Talis Biomedical Corporation
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
7 Small-Cap Stocks to Sell in August Before They Crash and Burn
Via InvestorPlace
Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update
From Talis Biomedical Corporation
Via GlobeNewswire
Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023
From Talis Biomedical Corporation
Via GlobeNewswire
Earnings Scheduled For August 10, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.